mortality/aging
• mutants have a median survival of 6.5 months compared to median survival of 10.8 months and 11.7 months of each single heterozygote respectively
|
neoplasm
• double heterzygotes show fewer tumors of this type compared with the single heterozygotes
|
• doubly heterozygous mice show an increase in metastatic disease compared to single heterozygotes
|
liver/biliary system
• double heterzygotes show fewer tumors of this type compared with the single heterozygotes
|